← Back to all trials
Not Yet Recruiting
NCT07839871
Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease
Conditions: Respiratory Syncytial Virus (RSV)
Sex: All
Ages: 5 Years – 17 Years
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 920
Sponsor: Pfizer
Location: Senders Pediatrics South Euclid Ohio
Summary
The purpose of the study is to evaluate the safety, tolerability, and immunogenicity of RSVpreF in children 5 to \
Eligibility Criteria
Key Inclusion Criteria:
* Participants' age requirements for each study cohort at enrollment, respectively Cohort 1a (chronic medical conditions) 12 to \
Source: ClinicalTrials.gov (NCT07839871). StuddyBuddy aggregates publicly available trial information.
